EE9700089A - Kompositsioonid ja meetodid nuumrakkude vahendatud põletikuluste seisundite raviks - Google Patents
Kompositsioonid ja meetodid nuumrakkude vahendatud põletikuluste seisundite raviksInfo
- Publication number
- EE9700089A EE9700089A EE9700089A EE9700089A EE9700089A EE 9700089 A EE9700089 A EE 9700089A EE 9700089 A EE9700089 A EE 9700089A EE 9700089 A EE9700089 A EE 9700089A EE 9700089 A EE9700089 A EE 9700089A
- Authority
- EE
- Estonia
- Prior art keywords
- compositions
- methods
- mast cell
- inflammatory conditions
- cell mediated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C271/34—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31226994A | 1994-09-23 | 1994-09-23 | |
| PCT/US1995/011814 WO1996009297A1 (en) | 1994-09-23 | 1995-09-14 | Compositions and methods for treating mast-cell inflammatory condition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE9700089A true EE9700089A (et) | 1997-10-15 |
| EE03525B1 EE03525B1 (et) | 2001-10-15 |
Family
ID=23210670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9700089A EE03525B1 (et) | 1994-09-23 | 1995-09-14 | Kompositsioonid nuumrakkude vahendatud põletikuliste seisundite raviks |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6022969A (et) |
| EP (1) | EP0782571A1 (et) |
| JP (1) | JPH10506390A (et) |
| KR (1) | KR970706267A (et) |
| CN (1) | CN1160398A (et) |
| AU (1) | AU694275B2 (et) |
| CA (1) | CA2200561A1 (et) |
| CZ (1) | CZ87097A3 (et) |
| EE (1) | EE03525B1 (et) |
| FI (1) | FI971171A0 (et) |
| HR (1) | HRP950499B1 (et) |
| HU (1) | HUT77770A (et) |
| IL (1) | IL115405A (et) |
| LT (1) | LT4234B (et) |
| LV (1) | LV11865B (et) |
| MX (1) | MX9702125A (et) |
| NO (1) | NO309605B1 (et) |
| NZ (1) | NZ294392A (et) |
| PL (1) | PL183552B1 (et) |
| RU (1) | RU2159229C2 (et) |
| SI (1) | SI9520101A (et) |
| SK (1) | SK37997A3 (et) |
| TW (1) | TW442478B (et) |
| WO (1) | WO1996009297A1 (et) |
| ZA (1) | ZA958028B (et) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ333713A (en) * | 1996-07-30 | 2000-12-22 | Axys Pharm Inc | Compounds for treating diseases associated with tryptase activity |
| WO1998024886A1 (en) * | 1996-12-04 | 1998-06-11 | Brigham And Women's Hospital, Inc. | Mast cell protease that cleaves fibrinogen |
| US5955431A (en) * | 1997-02-05 | 1999-09-21 | Brigham And Women's Hospital, Inc. | Mast cell protease peptide inhibitors |
| AU8997498A (en) * | 1997-09-05 | 1999-03-29 | Yoshitomi Pharmaceutical Industries, Ltd. | Tryptase inhibitor |
| WO1999024407A1 (en) * | 1997-11-10 | 1999-05-20 | Array Biopharma, Inc. | Compounds which inhibit tryptase activity |
| US6221914B1 (en) * | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
| JP2002502845A (ja) * | 1998-02-06 | 2002-01-29 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | トリプターゼ阻害物質 |
| US6489327B1 (en) | 1998-02-06 | 2002-12-03 | Max-Planck-Gesellschaft Zur Fordrungder Wisenschaften, E.V. | Tryptase inhibitors |
| CA2342855A1 (en) * | 1998-09-04 | 2000-03-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel pyranoses |
| US6362216B1 (en) | 1998-10-27 | 2002-03-26 | Array Biopharma Inc. | Compounds which inhibit tryptase activity |
| US6849605B1 (en) * | 1999-03-05 | 2005-02-01 | The Trustees Of University Technology Corporation | Inhibitors of serine protease activity, methods and compositions for treatment of viral infections |
| AU3731400A (en) * | 1999-03-05 | 2000-09-21 | Trustees Of University Technology Corporation, The | Methods and compositions useful in inhibiting apoptosis |
| AU777026B2 (en) * | 1999-08-10 | 2004-09-30 | Altana Pharma Ag | Novel tryptase inhibitors |
| WO2001019809A1 (en) * | 1999-09-14 | 2001-03-22 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tryptase inhibitors |
| GB9923710D0 (en) * | 1999-10-08 | 1999-12-08 | Proteus Molecular Design | Chemical compounds |
| AU1413301A (en) * | 1999-11-17 | 2001-05-30 | Sumitomo Pharmaceuticals Company, Limited | Diabetic remedy containing dipiperazine derivative |
| DE60011677T2 (de) * | 1999-12-20 | 2005-07-14 | Altana Pharma Ag | Tryptase-inhibitoren |
| ATE268322T1 (de) | 1999-12-20 | 2004-06-15 | Altana Pharma Ag | Inhibitoren der tryptase |
| AU2001231030A1 (en) * | 2000-01-20 | 2001-07-31 | Amgen Inc | Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics |
| US20020045613A1 (en) * | 2000-04-27 | 2002-04-18 | Heinz Pauls | 1-aroyl-piperidinyl benzamidines |
| US6924305B2 (en) | 2001-01-31 | 2005-08-02 | Altana Pharma Ag | Diazocine derivatives and their use as tryptase inhibitors |
| DE60217076T2 (de) | 2001-02-21 | 2007-06-21 | Altana Pharma Ag | Tryptaseinhibitoren |
| WO2002066420A2 (en) * | 2001-02-21 | 2002-08-29 | Altana Pharma Ag | Tryptase inhibitors |
| WO2002074732A2 (en) * | 2001-03-15 | 2002-09-26 | Altana Pharma Ag | Tryptase-inhibitors |
| AU2002254941B2 (en) * | 2001-03-15 | 2007-05-17 | Altana Pharma Ag | Tryptase-inhibitors |
| US6818787B2 (en) * | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7232924B2 (en) * | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| AU2002314165B2 (en) | 2001-06-19 | 2008-02-21 | Altana Pharma Ag | Tryptase inhibitors |
| EP1455765A2 (en) * | 2001-12-13 | 2004-09-15 | Kowa Company Ltd. | Use of protease-activated receptor-2 inhibitor in the manufacture of a medicament for treating delayed hypersensitivity |
| WO2003075853A2 (en) | 2002-03-08 | 2003-09-18 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| TW200524849A (en) * | 2003-07-02 | 2005-08-01 | Hoffmann La Roche | Hydroxyalkylamide derivatives |
| US20050255154A1 (en) * | 2004-05-11 | 2005-11-17 | Lena Pereswetoff-Morath | Method and composition for treating rhinitis |
| TW200815351A (en) * | 2006-05-02 | 2008-04-01 | Astrazeneca Ab | Novel compounds |
| TWI414527B (zh) * | 2010-10-06 | 2013-11-11 | Ind Tech Res Inst | 異山梨糖醇衍生物及包含該衍生物之液晶顯示器 |
| CN102453037B (zh) * | 2010-10-25 | 2014-06-25 | 财团法人工业技术研究院 | 异山梨糖醇衍生物及包含该衍生物的液晶显示器 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR208414A1 (es) * | 1974-11-07 | 1976-12-27 | Rhone Poulenc Ind | Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2) |
| US4746737A (en) * | 1985-07-26 | 1988-05-24 | Kowa Co., Ltd. | Phenyl guanidinobenzoate derivatives which have protease inhibitory activity |
| CZ289930B6 (cs) * | 1993-03-12 | 2002-04-17 | Axys Pharmaceuticals, Inc. | Arylové a heteroarylové peptidové deriváty a farmaceutické prostředky je obsahující |
| US5525623A (en) * | 1993-03-12 | 1996-06-11 | Arris Pharmaceutical Corporation | Compositions and methods for the treatment of immunomediated inflammatory disorders |
| WO1995032945A1 (en) * | 1994-06-01 | 1995-12-07 | Arris Pharmaceutical Corporation | Compositions and methods for treating mast-cell mediated conditions |
-
1995
- 1995-09-14 CN CN95195191A patent/CN1160398A/zh active Pending
- 1995-09-14 SK SK379-97A patent/SK37997A3/sk unknown
- 1995-09-14 RU RU97106347/04A patent/RU2159229C2/ru not_active IP Right Cessation
- 1995-09-14 SI SI9520101A patent/SI9520101A/sl unknown
- 1995-09-14 HU HU9702059A patent/HUT77770A/hu unknown
- 1995-09-14 CZ CZ97870A patent/CZ87097A3/cs unknown
- 1995-09-14 KR KR1019970701960A patent/KR970706267A/ko not_active Application Discontinuation
- 1995-09-14 US US08/522,157 patent/US6022969A/en not_active Expired - Fee Related
- 1995-09-14 MX MX9702125A patent/MX9702125A/es not_active IP Right Cessation
- 1995-09-14 EE EE9700089A patent/EE03525B1/et not_active IP Right Cessation
- 1995-09-14 PL PL95319587A patent/PL183552B1/pl unknown
- 1995-09-14 JP JP8511002A patent/JPH10506390A/ja not_active Ceased
- 1995-09-14 EP EP95934993A patent/EP0782571A1/en not_active Withdrawn
- 1995-09-14 WO PCT/US1995/011814 patent/WO1996009297A1/en not_active Application Discontinuation
- 1995-09-14 CA CA002200561A patent/CA2200561A1/en not_active Abandoned
- 1995-09-14 AU AU37180/95A patent/AU694275B2/en not_active Ceased
- 1995-09-14 NZ NZ294392A patent/NZ294392A/xx unknown
- 1995-09-22 ZA ZA958028A patent/ZA958028B/xx unknown
- 1995-09-22 HR HR950499A patent/HRP950499B1/xx not_active IP Right Cessation
- 1995-09-22 IL IL11540595A patent/IL115405A/en not_active IP Right Cessation
- 1995-09-26 TW TW084110031A patent/TW442478B/zh active
-
1997
- 1997-03-20 NO NO971305A patent/NO309605B1/no unknown
- 1997-03-20 FI FI971171A patent/FI971171A0/fi unknown
- 1997-04-10 LT LT97-065A patent/LT4234B/lt not_active IP Right Cessation
- 1997-04-22 LV LVP-97-70A patent/LV11865B/en unknown
-
1999
- 1999-03-29 US US09/280,227 patent/US6211228B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EE03525B1 (et) | 2001-10-15 |
| FI971171A (fi) | 1997-03-20 |
| TW442478B (en) | 2001-06-23 |
| CN1160398A (zh) | 1997-09-24 |
| IL115405A0 (en) | 1995-12-31 |
| PL319587A1 (en) | 1997-08-18 |
| CA2200561A1 (en) | 1996-03-28 |
| LV11865A (lv) | 1997-10-20 |
| RU2159229C2 (ru) | 2000-11-20 |
| NO309605B1 (no) | 2001-02-26 |
| HUT77770A (hu) | 1998-08-28 |
| NO971305D0 (no) | 1997-03-20 |
| NZ294392A (en) | 1999-05-28 |
| CZ87097A3 (en) | 1997-11-12 |
| JPH10506390A (ja) | 1998-06-23 |
| US6022969A (en) | 2000-02-08 |
| LT97065A (en) | 1997-08-25 |
| EP0782571A1 (en) | 1997-07-09 |
| SI9520101A (en) | 1997-12-31 |
| US6211228B1 (en) | 2001-04-03 |
| SK37997A3 (en) | 1998-12-02 |
| IL115405A (en) | 2002-07-25 |
| PL183552B1 (pl) | 2002-06-28 |
| ZA958028B (en) | 1996-04-18 |
| NO971305L (no) | 1997-05-06 |
| AU3718095A (en) | 1996-04-09 |
| HRP950499A2 (en) | 1997-08-31 |
| KR970706267A (ko) | 1997-11-03 |
| HRP950499B1 (en) | 2003-04-30 |
| LV11865B (en) | 1998-01-20 |
| FI971171A0 (fi) | 1997-03-20 |
| WO1996009297A1 (en) | 1996-03-28 |
| MX9702125A (es) | 1998-04-30 |
| AU694275B2 (en) | 1998-07-16 |
| LT4234B (en) | 1997-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE9700089A (et) | Kompositsioonid ja meetodid nuumrakkude vahendatud põletikuluste seisundite raviks | |
| NO20003096L (no) | Sammensetninger og fremgangsmÕter for behandling av ADD | |
| DE69518099D1 (de) | Leistungsverstärker und Verfahren dazu | |
| DE69516699D1 (de) | Schwindung reduzierende zementzusammensetzung | |
| EE9900247A (et) | Arvutamiseks kasutatav meetod ja aparatuur | |
| AU2366295A (en) | Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation | |
| FI961154A (fi) | Menetelmä ja järjestely matkapuhelimen käytön rajoittamiseksi | |
| EE9900468A (et) | Võimsusvõimendi ja selles kasutatav meetod | |
| FI965008A0 (fi) | Koostumukset ja menetelmät kasvainten hoitamiseksi | |
| FI981983A0 (fi) | Ohjausjärjestely ja menetelmä karsintalaitteistossa | |
| FI954245A (fi) | Koostumuksia ja menetelmiä immunovälitteisten tulehduksellisten häiriöiden hoitamiseksi | |
| BR9510062A (pt) | Macromonômeto esterificado e composição | |
| DE69529904T2 (de) | Dampfungsglied | |
| FI942298A0 (fi) | Menetelmä ja sovitelma tilaelementtien siirtämiseksi | |
| DE69516708T2 (de) | Nitro-benzamides verwendbar als antiarrythmica | |
| KR960009368A (ko) | 전력변환장치 및 전력변환장치용 제어장치 | |
| FI965173A0 (fi) | Impedanssiltaan korkea sähköoptinen muutin | |
| DE69722799D1 (de) | Zellzusammenstellungen | |
| FI940496A0 (fi) | Esijännittyvä ruuvi ja menetelmä esijännityksen toteuttamiseksi | |
| NO952766L (no) | Opplösningsmiddelsammensetninger og metoder | |
| DE69519308T2 (de) | Kraneinrichtung | |
| FI974619A (fi) | Menetelmä kattoristikkoelementtien valmistamiseksi ja menetelmässä käytettävä laite | |
| DE69514758T2 (de) | Wägezellen | |
| KR950034479U (ko) | 역율자동조정식 절전기 | |
| FI943748A (fi) | Koostumus ja menetelmä sappitiehyeiden puhdistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20030914 |